Regulus Therapeutics Probability of Future Stock Price Finishing Over 8.16
| RGLSDelisted Stock | USD 8.16 0.01 0.12% |
Regulus |
Regulus Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Regulus Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Regulus Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Regulus Therapeutics is not yet fully synchronised with the market data | |
| Regulus Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (46.36 M) with loss before overhead, payroll, taxes, and interest of (36.15 M). | |
| Regulus Therapeutics currently holds about 47.53 M in cash with (41.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.25. | |
| Over 83.0% of the company shares are owned by institutional investors |
Regulus Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Regulus Stock often depends not only on the future outlook of the current and potential Regulus Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Regulus Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 56.3 M | |
| Cash And Short Term Investments | 75.8 M |
Regulus Therapeutics Technical Analysis
Regulus Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Regulus Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regulus Therapeutics. In general, you should focus on analyzing Regulus Stock price patterns and their correlations with different microeconomic environments and drivers.
Regulus Therapeutics Predictive Forecast Models
Regulus Therapeutics' time-series forecasting models is one of many Regulus Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Regulus Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Regulus Therapeutics
Checking the ongoing alerts about Regulus Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Regulus Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Regulus Therapeutics is not yet fully synchronised with the market data | |
| Regulus Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (46.36 M) with loss before overhead, payroll, taxes, and interest of (36.15 M). | |
| Regulus Therapeutics currently holds about 47.53 M in cash with (41.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.25. | |
| Over 83.0% of the company shares are owned by institutional investors |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Regulus Stock
If you are still planning to invest in Regulus Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Regulus Therapeutics' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |